Vertex Pharmaceuticals, Inc. (VRTX)
541.69
-5.86
(-1.07%)
USD |
NASDAQ |
Aug 28, 16:00
541.81
+0.12
(+0.02%)
After-Hours: 20:00
Vertex Pharmaceuticals Cash and Short Term Investments (Quarterly) : 7.863B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.863B |
| March 31, 2026 | 7.259B |
| December 31, 2025 | 6.611B |
| September 30, 2025 | 6.295B |
| June 30, 2025 | 6.393B |
| March 31, 2025 | 6.212B |
| December 31, 2024 | 6.118B |
| September 30, 2024 | 6.533B |
| June 30, 2024 | 5.796B |
| March 31, 2024 | 10.17B |
| December 31, 2023 | 11.22B |
| September 30, 2023 | 11.93B |
| June 30, 2023 | 11.24B |
| March 31, 2023 | 10.42B |
| December 31, 2022 | 10.79B |
| September 30, 2022 | 9.776B |
| June 30, 2022 | 9.258B |
| March 31, 2022 | 8.243B |
| December 31, 2021 | 7.53B |
| September 30, 2021 | 6.965B |
| June 30, 2021 | 6.715B |
| March 31, 2021 | 6.933B |
| December 31, 2020 | 6.660B |
| September 30, 2020 | 6.154B |
| June 30, 2020 | 5.455B |
| Date | Value |
|---|---|
| March 31, 2020 | 4.199B |
| December 31, 2019 | 3.816B |
| September 30, 2019 | 4.003B |
| June 30, 2019 | 3.958B |
| March 31, 2019 | 3.478B |
| December 31, 2018 | 3.168B |
| September 30, 2018 | 3.064B |
| June 30, 2018 | 2.776B |
| March 31, 2018 | 2.487B |
| December 31, 2017 | 2.090B |
| September 30, 2017 | 1.814B |
| June 30, 2017 | 1.733B |
| March 31, 2017 | 1.453B |
| December 31, 2016 | 1.497B |
| September 30, 2016 | 1.187B |
| June 30, 2016 | 1.142B |
| March 31, 2016 | 1.102B |
| December 31, 2015 | 1.127B |
| September 30, 2015 | 1.082B |
| June 30, 2015 | 1.105B |
| March 31, 2015 | 1.181B |
| December 31, 2014 | 1.398B |
| September 30, 2014 | 1.478B |
| June 30, 2014 | 1.219B |
| March 31, 2014 | 1.324B |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 4.882B |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Sionna Therapeutics, Inc. | 211.03M |
| Regeneron Pharmaceuticals, Inc. | 8.005B |
| Biogen, Inc. | 1.285B |